Tracking CRDF? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CR
Cardiff Oncology, Inc. (CRDF) short interest & options flow
NASDAQLatest pulse15 May 2026
CRDF short interest utilization hits 92.56%, near its 52-week peak of 100%, signaling extremely tight share availability for borrowing despite flat cost-to-borrow at 11.17%.
$0.80+0.68% 1d-5.16% 1w-25.86% 1mClose: 9 Nov 2026
- Market cap
- $62M
- Next earnings
- 13 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.
Key data as of 10 Nov 2026
Latest signals on CRDF
- Utilization
CRDF short interest utilization hits 92.56%, near its 52-week peak of 100%, signaling extremely tight share availability for borrowing despite flat cost-to-borrow at 11.17%.
CRDF news and analysis
RSSNo long-form analysis yet for CRDF. Pulse alerts and the live data picture are available on ORTEX.
Open CRDF on ORTEX →Want the live picture for CRDF?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CRDF — free to start on ORTEX.
Sign up for free →Open CRDF on ORTEX